XTX Topco
AZR

XTX Topco’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

XTX Topco’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,084
Closed -$11.5K – 3783
2025
Q4 		$11.5K Buy
+2,084
New +$16.9K ﹤0.01% 3167

Other funds holding AZR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

XTX Topco's AZR Position: Q1 2026 in Review

XTX Topco sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q1 2026, closing a stake of 2,084 shares — an estimated $11.5K sold.

XTX Topco first reported a position in AZR in Q4 2025 and held it in 1 quarter. The position peaked at $11.5K in Q4 2025. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.

  • XTX Topco reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 2,084 Azora Therapeutics, Inc. Common Stock shares in Q1 2026, an estimated $11.5K.
  • XTX Topco first reported a position in Azora Therapeutics, Inc. Common Stock in Q4 2025 and held it in 1 quarter.
  • XTX Topco's Azora Therapeutics, Inc. Common Stock position peaked at $11.5K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.